These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

477 related items for PubMed ID: 17190862

  • 1. Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study.
    Ix JH, Shlipak MG, Chertow GM, Whooley MA.
    Circulation; 2007 Jan 16; 115(2):173-9. PubMed ID: 17190862
    [Abstract] [Full Text] [Related]

  • 2. Association of cystatin C with poor exercise capacity and heart rate recovery: data from the heart and soul study.
    McManus D, Shlipak M, Ix JH, Ali S, Whooley MA.
    Am J Kidney Dis; 2007 Mar 16; 49(3):365-72. PubMed ID: 17336697
    [Abstract] [Full Text] [Related]

  • 3. Kidney dysfunction and fatal cardiovascular disease--an association independent of atherosclerotic events: results from the Health, Aging, and Body Composition (Health ABC) study.
    Deo R, Fyr CL, Fried LF, Newman AB, Harris TB, Angleman S, Green C, Kritchevsky SB, Chertow GM, Cummings SR, Shlipak MG, Health ABC study.
    Am Heart J; 2008 Jan 16; 155(1):62-8. PubMed ID: 18082491
    [Abstract] [Full Text] [Related]

  • 4. Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease.
    Shlipak MG, Katz R, Sarnak MJ, Fried LF, Newman AB, Stehman-Breen C, Seliger SL, Kestenbaum B, Psaty B, Tracy RP, Siscovick DS.
    Ann Intern Med; 2006 Aug 15; 145(4):237-46. PubMed ID: 16908914
    [Abstract] [Full Text] [Related]

  • 5. Cystatin C concentration as a risk factor for heart failure in older adults.
    Sarnak MJ, Katz R, Stehman-Breen CO, Fried LF, Jenny NS, Psaty BM, Newman AB, Siscovick D, Shlipak MG, Cardiovascular Health Study.
    Ann Intern Med; 2005 Apr 05; 142(7):497-505. PubMed ID: 15809461
    [Abstract] [Full Text] [Related]

  • 6. Associations of pentraxin-3 with cardiovascular events, incident heart failure, and mortality among persons with coronary heart disease: data from the Heart and Soul Study.
    Dubin R, Li Y, Ix JH, Shlipak MG, Whooley M, Peralta CA.
    Am Heart J; 2012 Feb 05; 163(2):274-9. PubMed ID: 22305847
    [Abstract] [Full Text] [Related]

  • 7. Cystatin C identifies cardiovascular risk better than creatinine-based estimates of glomerular filtration in middle-aged individuals without a history of cardiovascular disease.
    Svensson-Färbom P, Ohlson Andersson M, Almgren P, Hedblad B, Engström G, Persson M, Christensson A, Melander O.
    J Intern Med; 2014 May 05; 275(5):506-21. PubMed ID: 24279862
    [Abstract] [Full Text] [Related]

  • 8. Cystatin C, left ventricular hypertrophy, and diastolic dysfunction: data from the Heart and Soul Study.
    Ix JH, Shlipak MG, Chertow GM, Ali S, Schiller NB, Whooley MA.
    J Card Fail; 2006 Oct 05; 12(8):601-7. PubMed ID: 17045178
    [Abstract] [Full Text] [Related]

  • 9. Cystatin-C and mortality in elderly persons with heart failure.
    Shlipak MG, Katz R, Fried LF, Jenny NS, Stehman-Breen C, Newman AB, Siscovick D, Psaty BM, Sarnak MJ.
    J Am Coll Cardiol; 2005 Jan 18; 45(2):268-71. PubMed ID: 15653026
    [Abstract] [Full Text] [Related]

  • 10. Association of resistin with heart failure and mortality in patients with stable coronary heart disease: data from the heart and soul study.
    Zhang MH, Na B, Schiller NB, Whooley MA.
    J Card Fail; 2011 Jan 18; 17(1):24-30. PubMed ID: 21187261
    [Abstract] [Full Text] [Related]

  • 11. Cystatin C and the risk of death and cardiovascular events among elderly persons.
    Shlipak MG, Sarnak MJ, Katz R, Fried LF, Seliger SL, Newman AB, Siscovick DS, Stehman-Breen C.
    N Engl J Med; 2005 May 19; 352(20):2049-60. PubMed ID: 15901858
    [Abstract] [Full Text] [Related]

  • 12. Cystatin C, a novel measure of renal function, is an independent predictor of cardiac events in patients with heart failure.
    Arimoto T, Takeishi Y, Niizeki T, Takabatake N, Okuyama H, Fukui A, Tachibana H, Nozaki N, Hirono O, Tsunoda Y, Miyashita T, Shishido T, Takahashi H, Koyama Y, Kubota I.
    J Card Fail; 2005 Oct 19; 11(8):595-601. PubMed ID: 16230262
    [Abstract] [Full Text] [Related]

  • 13. Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: more than simply a marker of glomerular filtration rate.
    Koenig W, Twardella D, Brenner H, Rothenbacher D.
    Clin Chem; 2005 Feb 19; 51(2):321-7. PubMed ID: 15563478
    [Abstract] [Full Text] [Related]

  • 14. High-Sensitivity Troponin I and Incident Coronary Events, Stroke, Heart Failure Hospitalization, and Mortality in the ARIC Study.
    Jia X, Sun W, Hoogeveen RC, Nambi V, Matsushita K, Folsom AR, Heiss G, Couper DJ, Solomon SD, Boerwinkle E, Shah A, Selvin E, de Lemos JA, Ballantyne CM.
    Circulation; 2019 Jun 04; 139(23):2642-2653. PubMed ID: 31030544
    [Abstract] [Full Text] [Related]

  • 15. Serum cystatin C and increased coronary heart disease prevalence in US adults without chronic kidney disease.
    Muntner P, Mann D, Winston J, Bansilal S, Farkouh ME.
    Am J Cardiol; 2008 Jul 01; 102(1):54-7. PubMed ID: 18572035
    [Abstract] [Full Text] [Related]

  • 16. Biomarkers to predict recurrent cardiovascular disease: the Heart and Soul Study.
    Shlipak MG, Ix JH, Bibbins-Domingo K, Lin F, Whooley MA.
    Am J Med; 2008 Jan 01; 121(1):50-7. PubMed ID: 18187073
    [Abstract] [Full Text] [Related]

  • 17. Cystatin C as risk factor for cardiovascular events and all-cause mortality in the general population. The Tromsø Study.
    Toft I, Solbu M, Kronborg J, Mathisen UD, Eriksen BO, Storhaug H, Melsom T, Løchen ML, Mathiesen EB, Njølstad I, Wilsgaard T, Brox J.
    Nephrol Dial Transplant; 2012 Jul 01; 27(7):2780-7. PubMed ID: 22207328
    [Abstract] [Full Text] [Related]

  • 18. Predictive value of long-term changes of growth differentiation factor-15 over a 27-year-period for heart failure and death due to coronary heart disease.
    Fluschnik N, Ojeda F, Zeller T, Jørgensen T, Kuulasmaa K, Becher PM, Sinning C, Blankenberg S, Westermann D.
    PLoS One; 2018 Jul 01; 13(5):e0197497. PubMed ID: 29771963
    [Abstract] [Full Text] [Related]

  • 19. Cystatin C is independently associated with total and cardiovascular mortality in individuals undergoing coronary angiography. The Ludwigshafen Risk and Cardiovascular Health (LURIC) study.
    Woitas RP, Kleber ME, Meinitzer A, Grammer TB, Silbernagel G, Pilz S, Tomaschitz A, Weihrauch G, Dobnig H, März W, Scharnagl H.
    Atherosclerosis; 2013 Aug 01; 229(2):541-8. PubMed ID: 23706287
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.